StemCell Therapy

3D Bioprinting Market Size, Growth, Trends and Share Analysis By Technology (Microextrusion Bioprinting, Inkjet 3D Bioprinting, Laser-assisted Bioprinting, Magnetic 3D Bioprinting), Material (Living Cells, Hydrogels, Extracellular Matrices), End-user and Region, Forecast To 2023

Global3D Bioprinting Marketsize is projected to reachUSD 1,923.02 Millionwith expanding at aCAGR of 24.59%By 2023. Currently, the 3D bioprinting is used to print tissues & organs and in the drug discovery. 3D Bioprinting is an emerging technology, which has the potential to transform the medical field with its capacity to bio fabricate living tissues & organs by combining a patients own cells with other biomaterials. Moreover, researchers, innovators, and early adopters are improving the performance of this disruptive technology stepwise, as it grows. The 3D bioprinting market is growing pervasively, mainly due to the burgeoning medical implant market.

The 3D bioprinting majorly involves the creation of simple tissue structures in lab settings. However, in the future, the technology is estimated to participate in the production of complete organs for transplants. It would also be used for swifter and more accurate drug testing. As potential drug compounds could be tested on bio-printed tissue before human trials have begun.

Request Free Sample Report at:https://www.marketresearchfuture.com/sample_request/869

Global 3D Bioprinting Market Segmentations:

The 3D bioprinting market is segmented by Technique, Application, Material and End User

By Technique the global 3D bioprinting market has been segmented intomicroextrusion bioprinting, inkjet 3d bioprinting, Magnetic 3d bioprinting and laser-assisted bioprinting.

By Application 3D bioprinting market has been segmented into Research (regenerative medicine, personalized healthcare, 3D cell culture, others) and Clinical (tissue transplantation, bone grafts, wound care, vascular grafts, others), among other several applications.

By Material3D bioprinting markethas been segmented intoExtracellular Matrices, Cells, Fibrinogen, Alginate, and Hydrogels, among others.

By End-user 3D bioprinting market has been segmented into Academic Institutes and Biotechnology Companies, among others.

Global 3D Bioprinting Market Regional Analysis:

North Americacommands the global market with largest 3D bioprinting market share. The presence players like Organovo Holdings, Inc. & Stratasys Ltd. and well-developed healthcare sectors in the region, drive the North American 3D bioprinting market growth. Besides, high healthcare expenditures, favorable government regulations, and huge patient population for organ transplantation boost the growth of the regional market. With the growing biotech sector, the North American 3D bioprinting market growth is expected to continue with its dominance in the years to come.

Europetakes the second largest global 3D Bioprinting market share. Factors such as the increased research & development activities driven by government support and funds are substantiating the regional 3D Bioprinting market growth. Heading with the increasing per capita healthcare expenditures in Germany, the UK, and France, the region is expected to grow during the forecast period.

TheAsia Pacific3D bioprinting market is emerging as a promising market globally. Vast patient pool and the burgeoning medical treatment market in the region attribute to the growth of the market. Growing 3D bioprinting markets in India and China, backed by the increasing awareness & improved lifestyle, provide impetus to the regional market surge. Besides, the improving economy in the region is expected to create opportunities in the 3D Bioprinting market during the forecast period.

Global 3D Bioprinting Market Competitive landscape

Highly competitive, the 3D bioprinting market appears to be fragmented with several players accounting for a substantial market share. To gain a substantially larger share in the market, these players incorporate strategic initiatives such as acquisitions & mergers, collaboration, expansion, and product & technology launch. Expansion in the emerging market helps them to extend their sales networks. On the other hand, some of the players appear to be reluctant to collaborate as engineering firms & suppliers do not provide CAD drawings/input to clients due to the risk of losing IP.

Major Players:

Players leading the 3D bio-printing market includeCellink AB (Sweden), Organovo Holdings, Inc. (US), Bio3D Technologies (Singapore), Stratasys Ltd. (US), Aspect Biosystems Ltd. (Canada), Fathom (US), Materialise (US), Envisiontec, Inc. (Germany), Allevi (US), Nano3D Biosciences, Inc. (US), 3Dynamic Systems Ltd. (UK), Cyfuse Biomedical KK (Tokyo), REGENHU (Switzerland), and Poietis (France), among others.

Industry/ Innovation /Related News:

CollPlant (the US), a 3D bioprinter material developer, announced the receiving an investment of USD 5.5 MN provided by a group of investors with a special interest in the 3D printing industry and from one its largest shareholder Ami Sagi.

CELLINK (Sweden), a 3D bioprinter and materials developer, launched a new six-printhead bioprinting system named BIO X6. The new six-printhead 3D bioprinting platform allows the combination of multiple materials, cells, and tools, featuring an intelligent exchangeable printhead system and CELLINKs patented Clean Chamber Technology to enhance advanced research & clinical applications.

inkClub AB (Sweden), an online retailer, announced the acquisition of 3D PRIMA (Sweden), an online store for 3D-Printers and filaments. 3D Prima is a fast-growing e-commerce player, and inkClub was one of the first to sell 3D-printing products online. The acquisition is aligned with inkClubs strategic initiative for expansion. InkClub has both the experience and e-commerce expertise, which is essential when 3d Prima, is growing.

Browse Full Report Details at:https://www.marketresearchfuture.com/reports/3d-bioprinting-market-869

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: [emailprotected]

Follow this link:
3D Bioprinting Market Size Is expected to Reach USD 1923.02 Million at a CAGR of 24.59% By 2023 - Cole of Duty

This entry was posted on July 9, 2020 at 6:44 pm and is filed under Regenerative Medicine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |